Christian F. Krieglstein, Wolfgang H. Cerwinka, Andrew G. Sprague, F. Stephen Laroux, Matthew B. Grisham, Victor E. Koteliansky, Norbert Senninger, D. Neil Granger, Antonin R. de Fougerolles
Expression of α1β1 on CD11b+ cells is restricted to monocytes/macrophages, and in vivo blockade of α1β1 results in decreased number and activation state of monocytes/macrophages infiltrating the lamina propria. Colonic cross sections from WT mice that were treated for 7 days with DSS were stained with a combination of directly labeled mAb’s: (a) FITC anti-CD11b and PE anti-Gr1 mAb’s; (b) Alexa 488 anti-α1 and PE anti-Gr1 mAb’s; (c) Alexa 488 anti-α1 and PE anti-CD11b mAb’s; (d) Alexa 488 anti-α1 and PE anti-F4/80 mAb’s. Expression of α1β1 on CD11b+ cells was restricted to monocytes and macrophages as judged by its colocalization on F4/80+ and CD11b+Gr1– cells. Gr1 and F4/80 are granulocyte and monocyte/macrophage markers, respectively. The effect of in vivo α1β1 blockade on the number and activation state of the monocytes/macrophages infiltrating the lamina propria was quantitated by dual-color immunohistochemical analysis using F4/80 and CD14 mAb’s (e). The number of F4/80+ (black bars) cells per hpf and the percentage of CD14+ (white bars) F4/80 cells infiltrating the lamina propria following various treatment regimens (outlined in legends for Figure 1 and Figure 3) was quantitated. Data are expressed as number of F4/80+ cells per hpf and percentage of F4/80+ cells expressing the CD14 activation marker, mean ± SEM. In a–d, magnification is ×200 and bar represents 50 μm.